电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

CXCL3 Protein (AA 35-107) (His tag,GST tag)

CXCL3 宿主: 人 宿主: 大肠杆菌(E. Coli) Recombinant > 95 % SDS, WB, Imm, PC
产品编号 ABIN7414855
发货至: 中国
  • 抗原 See all CXCL3 蛋白
    CXCL3 (Chemokine (C-X-C Motif) Ligand 3 (CXCL3))
    蛋白类型
    Recombinant
    产品特性
    AA 35-107
    宿主
    • 6
    • 5
    • 3
    • 1
    • 1
    资源
    • 12
    • 2
    • 1
    • 1
    • 1
    大肠杆菌(E. Coli)
    标记
    This CXCL3 protein is labelled with His tag,GST tag.
    应用范围
    SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
    序列
    Ala35-Asn107 (Accession # P19876)
    产品特性
    Recombinant Chemokine (C-X-C Motif) Ligand 3 (CXCL3), Prokaryotic expression, Ala35-Asn107 (Accession # P19876), N-terminal His and GST Tag
    纯度
    > 95 %
    Top Product
    Discover our top product CXCL3 蛋白
  • 应用备注
    Optimal working dilution should be determined by the investigator.
    说明

    Isoelectric Point:8.3

    限制
    仅限研究用
  • 状态
    Lyophilized
    缓冲液
    PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
    储存液
    ProClin
    注意事项
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    4 °C,-80 °C
    储存方法
    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
    有效期
    12 months
  • 抗原
    CXCL3 (Chemokine (C-X-C Motif) Ligand 3 (CXCL3))
    别名
    Chemokine (C-X-C Motif) Ligand 3 (CXCL3 产品)
    别名
    CXCL3 Protein, CINC-2b Protein, GRO3 Protein, GROg Protein, MIP-2b Protein, MIP2B Protein, SCYB3 Protein, Cinc-2 Protein, Cinc2 Protein, Gm1960 Protein, Dcip1 Protein, C-X-C motif chemokine ligand 3 Protein, chemokine (C-X-C motif) ligand 3 Protein, CXCL3 Protein, Cxcl3 Protein
    背景
    GROg, SCYB3, GRO3, GRO-G, MIP2-B, MIP2b, CINC2b, CINC2b, Growth Regulated Oncogene Gamma, Macrophage inflammatory protein 2-beta
    UniProt
    P19876
    途径
    Cellular Response to Molecule of Bacterial Origin, Autophagy
You are here: